XORTX Therapeutics Announces 1-For-9 Share Consolidation
XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ:XRTX, TSXV:XRTX, Frankfurt: ANU)))), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease,
